By David Bautz, PhD NASDAQ: ASBP Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) is attempting something relatively uncommon ...

Acrux is a successful Australian pharmaceutical company that develops innovative drugs for the global market. It recently announced its new strategy to enter the final, phase III clinical trial, stage ...

From research labs to patient delivery, pharmaceutical ERP systems like SAP S/4HANA are transforming how drug companies operate. They unify data, streamline compliance, and optimize supply chains in a ...

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...

Figure 1. A typical polysiloxane structure, where R = CH3, phenyl (aromatic carbon ring), F3CCH2CH2, and CHCH2.(click image to enlarge) Drug-delivery systems are some of the most rapidly proliferating ...

Drawing on insights from the global regulatory landscape, industry trends, and direct feedback from customers, Dr. Di Wu ...

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...

An Australian research team has achieved an advanced materials breakthrough that opens the door to a new generation of nanodrug applications. From drug delivery, to diagnostics, to gene editing and ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the 'Company” or 'Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the filing of a ...

Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.